Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Proven process to optimize commercial readiness.
April 4, 2023
By: dr anna schamberger
Vetter
Bringing a new drug product to market can be a major challenge when it comes to guiding the late-stage development through to commercial readiness and launch. In fact, this is often considered one of the most impactful milestones of any drug program, because it culminates years of development work. It is usually during late-stage development, where there is a mindset shift from developing a drug product to commercializing it. Since timing is a crucial factor, decisive and focused launch management is required and involves a dedicated and experienced team to coordinate all necessary process steps. A successful first commercial production can be achieved in a predetermined timeline by following a thorough step-by-step approach.
The biopharma product launch landscape is very diverse, and as such, the needs of each product to reach the market can vary significantly. To effectively establish a plan for launch management, the contract development and manufacturing organization (CDMO) partner needs to work closely with the customer to decide on the product-specific process. Part of the launch is designing a tried-and-true methodology to meet the specific needs of each molecule to bring both, a small batch as well as a blockbuster drug to market. Throughout the launch management process, the team is working against the launch date with the intentions to follow the best product implementation strategy for commercial market supply.
Generally, when customers prepare for launch, they have already been collaborating with a CDMO partner and have an assigned project manager who helps guide their drug product through clinical development. When the launch management process begins, customers are paired with a launch manager, in addition to their project manager, to guide them through the journey to commercial production. At this point, the project manager assumes a new role within the launch team, and the launch manager takes the lead. The customer has access to both, the project and launch teams throughout the journey to commercial readiness. Though the managers will support the seamless step-by-step approach, external factors such as material or active pharmaceutical ingredient (API) supply must be closely monitored to avoid challenges that may arise and are outside the control of the service provider and customer.
Transparency and open communication on risks and active management of expectations are paramount to make sure all parties involved agree on each process steps. A proven step-by-step approach contributes significant value to achieving market launch on time and allows the customer and partner to keep track of several activities running in parallel, preventing overlooked gaps or missed milestones.
The launch management process is initiated based on the customers product launch plan. This phase allows both parties to define the organizational structure as well as the requirements and expectations for the timeline to bring the product to market. With large teams from various departments such as quality control, demand management and supply chain management involved in the process, it is important to identify the roles and responsibilities of each member. This applies to the filling partner as well as the customer launch teams.
The kickoff follows the start of product transfer from project to commercial. This phase includes internal and external kickoff meetings to get all relevant stakeholders involved in the process. During the latter, the service provider introduces the launch management process and provides a full project and product overview to the launch teams. The customer in turn provides a full overview on their final product set up for commercial and their understanding of launch management. This is also when project manager, launch manager and customer will align on milestones, common goals, timelines, and identify risk factors. Once the project manager hands the lead over to the launch manager, they confirm a joint understanding of the overall approach, the future commercial working frame, and the supply chain management process. Assuming there is agreement on the communication and core team setup, the kickoff is complete.
During the launch phase, a filling partner will establish a methodical way of working with the team including both internal and external players. This step also includes gaps and opening actions within a launch checklist developed in collaboration with the customer. Progress made throughout the launch phase is tracked during the regular meetings both internally, within the CDMO, and externally with the customer, to maintain open lines of communication. It is common during this phase to evaluate both best-case and worst-case forecasts to correspond with the planning of the launch and to develop corresponding scenarios to support flexible handling of the process throughout.
In an effort to conduct commercial setup, the launch management team will allocate process topics e.g. the API allocation, setup primary packaging, management supply, API storage and clean room equipment to match the customer’s forecasting needs and logistics process. Throughout commercial setup, there is an overall awareness of the anticipated timeline and processes, as well as dependencies on both the CDMO and the customer. As the process goes on and milestones are met, action items on the launch checklist are checked off. If there are any risks, whether related to supply chain, packaging, or otherwise, that might delay launch, they are flagged in this phase of the process.
This phase marks the completion of product transfer from project to commercial teams and the execution of the first commercial fill within the pre-planned scenario. Most of the defined activities must be completed by the launch tracker such as packaging material availability, personnel training and adherence of correct shipping processes and requirements. Also, all necessary orders are placed, and the availability of crucial components are confirmed.
Following the successful release of the first launch batch, a formal close-down of the project commences. The CDMO team will collect lessons-learned and feedback from the customer to optimize execution of future launches. Learning occurs on both sides – the customer learns how to better get their products to launch, and the filling partner learns how to further improve its launch management process.
Once a launch batch of the drug product is released, the formal close-down within the system is complete and the project manager and project team are released. At this point, the product has made its way through the launch management process and is now in the hands of the commercial team. The commercial team will remain responsible for continuous process verification, monitoring key performance indicators and yield data, forecasting and capacity reservation for medication, participating in business review and quality management review meetings, and managing the future lifecycle activities of the product.
Dr. Anna Schamberger has more than 10 years of experience in the pharmaceutical industry, primarily working with CDMOs. After joining Vetter in 2016, she began in customer project management leading late-stage drug product and life cycle projects. Since 2020, Dr. Schamberger has been a director in customer project management, leading a team of eight project managers. She is also a program manager for strategic partnerships, overlooking and leading product portfolio and supports multiple key strategic and operational activities within Vetter’s customer project management, achieving customer goals to commercialize innovative and life-saving products for a global market.
Sabrina Schumacher has 15 years of experience at Vetter and over seven years of experience as a customer relations manager, leading several launches for various customers in the function of a launch manager. She supports customers as a central contact and knowledge carrier within the company and develops solutions to complex challenges throughout the commercial development phase. Since 2020, she has been the team lead for customer service, leading a team of nine customer service representatives.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !